Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Gains from Sales and Divestitures (2021 - 2024)

Updated

Senti Biosciences Holdings' Gains from Sales and Divestitures was $107,000 in Q4 2024.

Analysis

Senti Biosciences Holdings (SNTI) Gains from Sales and Divestitures (2021 - 2024) Analysis & Trends

For FY2023, Gains from Sales and Divestitures at Senti Biosciences Holdings came in at $21.86 million.

  • In earlier years, Gains from Sales and Divestitures was -$22,000 in FY2021.
  • The Q4 2024 figure marks the highest quarterly Gains from Sales and Divestitures since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Senti Biosciences Holdings 9.97 Mn 9.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 107,000.00
Sep 30, 2024 -37,000.00
Sep 30, 2023 21.86 Mn
Sep 30, 2022 13,000.00
Jun 30, 2022 -1,000.00
Mar 31, 2022 -12,000.00
Dec 31, 2021 -13,000.00
Sep 30, 2021 -9,000.00
API Access

Senti Biosciences Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SNTI&period=max&api_key=YOUR_API_KEY